Find clinical trials for Chronic Lymphocytic Leukemia in Indianapolis, IN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

B-Cell Chronic Lymphocytic Leukemia

Leukemia

Lymphoma

Lymphoid Leukemia

Mantle-Cell Lymphoma

Diffuse Large B-Cell Lymphoma

Non-Hodgkin Lymphoma

Chronic Lymphocytic Leukemia trials near Indianapolis, IN, USA:

Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)

This is a Phase 1/2, open-label, multicenter study to determine the efficacy and safety of JCAR017 in adult subjects with relapsed or refractory CLL...

Enrolling

Lymphoma, Small Lymphocytic

Leukemia, Lymphocytic, Chronic, B-Cell

Biological: JCAR017 (lisocabtagene maraleucel) + venetoclax

Biological: JCAR017 (lisocabtagene maraleucel) + ibrutinib

Phase 1, Phase 2

Juno Therapeutics

Indianapolis, Indiana, United States and 82 other locations

Study of LOXO-305 (Pirtobrutinib) Versus Investigator's Choice (Idelalisib Plus Rituximab or Bendamustine Plus Rituximab) in Patients With Previously Treated Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) (BRUIN CLL-321)

This is a study for patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) who have...

Active, not recruiting

Small Lymphocytic Lymphoma

Chronic Lymphocytic Leukemia

Drug: Pirtobrutinib

Drug: Bendamustine

Phase 3

Loxo Oncology

Indianapolis, Indiana, United States and 231 other locations

Study to Evaluate Adverse Events and Change in Disease Activity in Adult Participants With B-Cell Malignancies Receiving Oral ABBV-525 Tablets

B-cell malignancies are a group of cancers of B lymphocytes, a type of white blood cell responsible for fighting infections. The purpose of ...

Enrolling

Chronic Lymphocytic Leukemia

Non-Hodgkin's Lymphoma

Drug: ABBV-525

Phase 1

AbbVie

Indianapolis, Indiana, United States and 36 other locations

Study of Oral LOXO-338 in Patients With Advanced Blood Cancers

The purpose of this study is to find out whether the study drug, LOXO-338, is safe and effective in patients with advanced blood cancer. Patients mus...

Active, not recruiting

Leukemia, Lymphocytic, Chronic, B-Cell

Lymphoma, B-cell Marginal Zone

Drug: LOXO-338

Drug: Pirtobrutinib

Phase 1

Lilly

Indianapolis, Indiana, United States and 22 other locations

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms